Influenza Vaccination Market Report

Global and Region Influenza Vaccination Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：234
  • REPORT CODE：GMM966903
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches.

    Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.

    The report details the trend, potential and market size of Influenza Vaccination market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Vaccinationmarket, defines the market attractiveness level of Influenza Vaccination market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenza Vaccination industry, describes the types of Influenza Vaccination market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Vaccination market and the development prospects and opportunities of Influenza Vaccination industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Vaccination market in Chapter 13.

    By Player:

    • GlaxoSmithKline plc (Europe)

    • AstraZeneca (Europe)

    • Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

    • Novartis AG (Europe)

    • Sanofi (Europe)

    • F Hoffmann-La Roche Ltd (Europe)

    • BioCryst Pharmaceuticals, Inc (US)

    • Abbott (US)

    • DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

    • Hualan Biological Engineering Inc (Asia Pacific)

    By Type:

    • Egg Based

    • Cell Culture

    • Recombinant

    By End-User:

    • Hospitals

    • Research Organizations

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenza Vaccination Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenza Vaccination Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenza Vaccination Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenza Vaccination Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenza Vaccination Market Analysis and Outlook to 2022

    • 7.1 Global Influenza Vaccination Consumption (2017-2022)

    • 7.2 United States Influenza Vaccination Consumption (2017-2022)

    • 7.3 Europe Influenza Vaccination Consumption (2017-2022)

    • 7.4 China Influenza Vaccination Consumption (2017-2022)

    • 7.5 Japan Influenza Vaccination Consumption (2017-2022)

    • 7.6 India Influenza Vaccination Consumption (2017-2022)

    • 7.7 South Korea Influenza Vaccination Consumption (2017-2022)

    8 Region and Country-wise Influenza Vaccination Market Analysis and Outlook to 2028

    • 8.1 Global Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.2 United States Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.3 Europe Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.4 China Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.5 Japan Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.6 India Influenza Vaccination Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenza Vaccination Consumption Forecast (2022-2028)

    9 Global Influenza Vaccination Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Vaccination Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Egg Based Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cell Culture Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Recombinant Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Vaccination Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Research Organizations Consumption and Growth Rate (2017-2022)

    10 Global Influenza Vaccination Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenza Vaccination Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Egg Based Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Cell Culture Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Recombinant Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenza Vaccination Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenza Vaccination Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenza Vaccination Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenza Vaccination Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenza Vaccination Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenza Vaccination Market Competitive Analysis

    • 14.1 GlaxoSmithKline plc (Europe)

      • 14.1.1 GlaxoSmithKline plc (Europe) Company Details

      • 14.1.2 GlaxoSmithKline plc (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline plc (Europe) Influenza Vaccination Product and Service

    • 14.2 AstraZeneca (Europe)

      • 14.2.1 AstraZeneca (Europe) Company Details

      • 14.2.2 AstraZeneca (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AstraZeneca (Europe) Influenza Vaccination Product and Service

    • 14.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)

      • 14.3.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details

      • 14.3.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product and Service

    • 14.4 Novartis AG (Europe)

      • 14.4.1 Novartis AG (Europe) Company Details

      • 14.4.2 Novartis AG (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis AG (Europe) Influenza Vaccination Product and Service

    • 14.5 Sanofi (Europe)

      • 14.5.1 Sanofi (Europe) Company Details

      • 14.5.2 Sanofi (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi (Europe) Influenza Vaccination Product and Service

    • 14.6 F Hoffmann-La Roche Ltd (Europe)

      • 14.6.1 F Hoffmann-La Roche Ltd (Europe) Company Details

      • 14.6.2 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product and Service

    • 14.7 BioCryst Pharmaceuticals, Inc (US)

      • 14.7.1 BioCryst Pharmaceuticals, Inc (US) Company Details

      • 14.7.2 BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Product and Service

    • 14.8 Abbott (US)

      • 14.8.1 Abbott (US) Company Details

      • 14.8.2 Abbott (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abbott (US) Influenza Vaccination Product and Service

    • 14.9 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific)

      • 14.9.1 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Company Details

      • 14.9.2 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Product and Service

    • 14.10 Hualan Biological Engineering Inc (Asia Pacific)

      • 14.10.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details

      • 14.10.2 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenza Vaccination

    • Figure Influenza Vaccination Picture

    • Table Global Influenza Vaccination Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Vaccination Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Vaccination Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenza Vaccination Consumption by Country (2017-2022)

    • Figure United States Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure China Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Vaccination Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Vaccination Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Vaccination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Egg Based Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Culture Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Research Organizations Consumption and Growth Rate (2017-2022)

    • Figure Global Egg Based Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Culture Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenza Vaccination Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenza Vaccination Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline plc (Europe) (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc (Europe) Influenza Vaccination Product and Service

    • Table AstraZeneca (Europe) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (Europe) Influenza Vaccination Product and Service

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) (Foundation Year, Company Profile and etc.)

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product and Service

    • Table Novartis AG (Europe) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Europe) Influenza Vaccination Product and Service

    • Table Sanofi (Europe) (Foundation Year, Company Profile and etc.)

    • Table Sanofi (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (Europe) Influenza Vaccination Product and Service

    • Table F Hoffmann-La Roche Ltd (Europe) (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product and Service

    • Table BioCryst Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCryst Pharmaceuticals, Inc (US) Influenza Vaccination Product and Service

    • Table Abbott (US) (Foundation Year, Company Profile and etc.)

    • Table Abbott (US) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott (US) Influenza Vaccination Product and Service

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) (Foundation Year, Company Profile and etc.)

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table DAIICHI SANKYO COMPANY, LIMITED (Asia Pacific) Influenza Vaccination Product and Service

    • Table Hualan Biological Engineering Inc (Asia Pacific) (Foundation Year, Company Profile and etc.)

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US